Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
Clicks: 113
ID: 269438
2021
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.6
/100
2 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage ...| Reference Key |
sepsis)2021annalshigher
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Julie Helms, François Severac, Hamid Merdji, Maleka Schenck, Raphaël Clere-Jehl, Mathieu Baldacini, Mickaël Ohana, Lélia Grunebaum, Vincent Castelain, Eduardo Anglés-Cano, Laurent Sattler, Ferhat Meziani, for the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care Sepsis Trial Group for Global EvaluationResearch in Sepsis);Julie Helms;François Severac;Hamid Merdji;Maleka Schenck;Raphaël Clere-Jehl;Mathieu Baldacini;Mickaël Ohana;Lélia Grunebaum;Vincent Castelain;Eduardo Anglés-Cano;Laurent Sattler;Ferhat Meziani;for the CRICS TRIGGERSEP Group (Clinical Research in Intensive Care Sepsis Trial Group for Global EvaluationResearch in Sepsis); |
| Journal | annals of intensive care |
| Year | 2021 |
| DOI | 10.1186/s13613-021-00809-5 |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.